Patent Assignment
Reel/Frame 057818/0643
Corrective Assignment to Correct the Application Number of Pct/US19/22717 in the Appendix I , Which Erroneously Inputted as Pct/US16/22717 Previously Recorded at Reel: 057597 Frame: 0774. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2021-10-15
Pages: 7
Assignor
SYNBLIA THERAPEUTICS, INC.
Executed: 2021-08-20
Assignee
CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
NO. 2, FLOOR 2, RONGYAO BUILDING, 5 KEYUAN SOUTH ROAD, CHENGDU HI-TECH INDUSTRIAL DEVELOPMENT ZONE, SICHUAN PROVINCE, CHINA
Covered Property
(1)
SHP2 Inhibitors and Uses Thereof
PCT:
PCT/US2019/022717 ↗
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 18, 2019
From: XIE, YINONG; BABISS, LEE E.
To: SYNBLIA THERAPEUTICS, INC.
Reel/Frame 048932/0755 →
Assignment of Assignor's Interest
Sep 15, 2021
From: SYNBLIA THERAPEUTICS, INC.
To: CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
Reel/Frame 057597/0774 →
Assignment of Assignor's Interest
Sep 29, 2021
From: CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
To: SUZHOU PUHE BIOPHARMA CO., LTD.
Reel/Frame 057648/0120 →
Corrective Assignment to Correct the Application Number of Pct/US19/22717 in the Appendix I, Which Erroneously Inputted as Pct/US16/22717 Previously Recorded at Reel: 057648 Frame: 0120. Assignor(S) Hereby Confirms the Assignment.
Oct 15, 2021
From: CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
To: SUZHOU PUHE BIOPHARMA CO., LTD.
Reel/Frame 057820/0077 →